Detalles de la búsqueda
1.
Rifapentine With and Without Moxifloxacin for Pulmonary Tuberculosis in People With Human Immunodeficiency Virus (S31/A5349).
Clin Infect Dis
; 76(3): e580-e589, 2023 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36041016
2.
1-Year Incidence of Tuberculosis Infection and Disease Among Household Contacts of Rifampin- and Multidrug-Resistant Tuberculosis.
Clin Infect Dis
; 77(6): 892-900, 2023 09 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37227925
3.
Efavirenz Pharmacokinetics and Human Immunodeficiency Virus Type 1 (HIV-1) Viral Suppression Among Patients Receiving Tuberculosis Treatment Containing Daily High-Dose Rifapentine.
Clin Infect Dis
; 75(4): 560-566, 2022 09 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34918028
4.
Population Pharmacokinetic Modeling and Simulation of Rifapentine Supports Concomitant Antiretroviral Therapy with Efavirenz and Non-Weight Based Dosing.
Antimicrob Agents Chemother
; 66(9): e0238521, 2022 09 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35943252
5.
One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis.
N Engl J Med
; 380(11): 1001-1011, 2019 03 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-30865794
6.
Pharmacogenetic interactions of rifapentine plus isoniazid with efavirenz or nevirapine.
Pharmacogenet Genomics
; 31(1): 17-27, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32815870
7.
An Evaluation of Baseline Kidney Function in the REPRIEVE Trial of Pitavastatin in Human Immunodeficiency Virus.
J Infect Dis
; 222(Suppl 1): S41-S51, 2020 07 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32645164
8.
Willingness to Take Multidrug-resistant Tuberculosis (MDR-TB) Preventive Therapy Among Adult and Adolescent Household Contacts of MDR-TB Index Cases: An International Multisite Cross-sectional Study.
Clin Infect Dis
; 70(3): 436-445, 2020 01 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-30919881
9.
Feasibility of Identifying Household Contacts of Rifampin-and Multidrug-resistant Tuberculosis Cases at High Risk of Progression to Tuberculosis Disease.
Clin Infect Dis
; 70(3): 425-435, 2020 01 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-30942853
10.
Toxicity related to standard TB therapy for pulmonary tuberculosis and treatment outcomes in the REMoxTB study according to HIV status.
BMC Pulm Med
; 19(1): 152, 2019 Aug 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-31412895
11.
Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB study.
BMC Med
; 16(1): 46, 2018 03 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-29592805
12.
Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial.
Lancet
; 387(10024): 1198-209, 2016 Mar 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-27025337
13.
Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis Prevention.
Clin Infect Dis
; 61(8): 1322-7, 2015 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26082504
14.
Timing of antiretroviral therapy for HIV-1 infection and tuberculosis.
N Engl J Med
; 365(16): 1482-91, 2011 Oct 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-22010914
15.
Antiretroviral therapies in women after single-dose nevirapine exposure.
N Engl J Med
; 363(16): 1499-509, 2010 Oct 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-20942666
16.
Effect of the relationship between anaemia and systemic inflammation on the risk of incident tuberculosis and death in people with advanced HIV: a sub-analysis of the REMEMBER trial.
EClinicalMedicine
; 60: 102030, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37287871
17.
Factors associated with prevalent Mycobacterium tuberculosis infection and disease among adolescents and adults exposed to rifampin-resistant tuberculosis in the household.
PLoS One
; 18(3): e0283290, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36930628
18.
Nevirapine- versus lopinavir/ritonavir-based initial therapy for HIV-1 infection among women in Africa: a randomized trial.
PLoS Med
; 9(6): e1001236, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22719231
19.
Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in adults living with HIV.
AIDS
; 36(3): 373-382, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34750291
20.
Third-line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource-limited settings: ACTG A5288 strategy trial.
J Int AIDS Soc
; 25(6): e25905, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36039892